Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05120843
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH), University of Pennsylvania (Other)
106
1
1
7.3
14.5

Study Details

Study Description

Brief Summary

This study continues an adaptation of care coordination to address the needs of women after preterm birth. This is a small single arm open trial designed to test intervention implementation and refine the intervention before ongoing feasibility testing.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Care coordination and motivational interviewing
N/A

Detailed Description

Interventionists will be trained in care coordination strategies and Motivational Interviewing (MI) techniques. Following training, investigators will enroll eligible women from a postpartum unit at a single hospital, or within two weeks of birth. Investigators will assess feasibility, adoption, reach, and fidelity of the intervention and of study data collections strategies. The intervention protocol will be revised to reflect these assessments.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
106 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Feasibility Testing of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth
Actual Study Start Date :
Feb 3, 2022
Anticipated Primary Completion Date :
Sep 13, 2022
Anticipated Study Completion Date :
Sep 13, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Intervention Arm

This intervention will combine care coordination and motivational interviewing strategies.

Behavioral: Care coordination and motivational interviewing
Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.

Outcome Measures

Primary Outcome Measures

  1. Screening Rate (feasibility) [Enrollment through six months]

    The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.

  2. Enrollment Rate (feasibility) [Enrollment through six months]

    The study team will track the proportion of eligible women approached for enrollment who enroll in the study.

  3. Reasons for non-participation (acceptability) [Enrollment through six months]

    For women who decline enrollment we will ask them, if they are willing, to provide reasons for non-participation and potential study modifications that might have encouraged them to participate. Responses will be tabulated and reviewed for potential themes.

  4. Retention rate (feasibility) [Enrollment through six months]

    The study team will track the proportion of enrolled participants who complete the intervention and the study assessments.

  5. Number of Completed Assessments (feasibility) [Enrollment through six months]

    The study team will track the proportion of the baseline, 3-month, and 6-month assessments that are completed.

  6. Care coordination fidelity (feasibility) [Enrollment through six months]

    We will assess the proportion of intervention components completed, including interventionist completion of screening tools, as well as other tasks outlined in the care plan, including focused education, navigation, and addressing barriers to care, screening.

  7. Motivational interviewing (MI) fidelity (feasibility) [Enrollment through six months]

    OnePass is a validated tool used to evaluate MI practice and assess fidelity based on review of a single session, using 23 items to assess MI components.61 This tool yields a global score while also identifying specific areas for additional practice and training. Scores range from 1 - 7 with 5 considered a minimum for competence. Interventionists will complete at least one OnePass within a month of starting MI sessions with participants.

Secondary Outcome Measures

  1. Change in Autonomy Support [Baseline and 3 months]

    Autonomy support will be measured with the short form of the Health Care Climate Questionnaire (6 items, range 6 - 42, Cronbach alpha 0.82). Scores on the short form 6-item version are calculated by averaging the individual item scores. Higher average scores represent a higher level of perceived autonomy support.

  2. Change in Autonomous motivation [Baseline and 6 months]

    Autonomous motivation will be measured using the Autonomous Motivation and External Regulation scales of the Treatment Self-Regulation Questionnaire (10 items, range 7 - 70, Cronbach alpha 0.90) with a higher score indicating higher emotion regulation strategy.

  3. Count of preventive care visits [6 months]

    This will include postpartum visits, visits for contraceptive management, routine preventive care visits, and visits to follow-up on complications of pregnancy (secondary prevention). Visits will be abstracted from the health record and from interventionist records.

  4. Proportion of recommended care completed [6 months]

    Recommended care will be abstracted from a care plan completed within the first two weeks after enrollment. Completed care will be abstracted from the health record and from interventionist records.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Female

  2. Less than 45 years old

  3. History of preterm birth (< 34 weeks gestational age or 34 - 36 weeks with identifiable risk factors for recurrent preterm birth which may include low preventive care utilization, tobacco use, obesity, depression or anxiety, or history of unmet contraceptive needs)

  4. Intention to seek pediatric care at one of two pediatric primary care sites

  5. Medicaid insurance

Exclusion Criteria:
  1. History of sterilization procedure.

  2. Plan to move away from the area or transfer pediatric primary care within six months of enrollment.

  3. Limited English proficiency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Children's Hospital of Philadelphia
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of Pennsylvania

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT05120843
Other Study ID Numbers:
  • 20-017871
  • 1K23HD102560
First Posted:
Nov 15, 2021
Last Update Posted:
Feb 8, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Children's Hospital of Philadelphia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022